Report Detail
Transplantation Diagnostics Global Market - Forecast to 2022
- RnM3925052 |
- 12 March, 2020 |
- Global |
- 303 Pages |
- IQ4I Research & Consultancy |
- Biotechnology
Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of the body and grafted into another area of the same individual or another individual of same species or different species. The solid organ, tissue and stem cell transplantation field has evolved from a clinical experiment to routine and reliable practice, which has proven to be clinically effective, life-saving and cost-effective. The transplantation diagnostics market is segmented based on the technology, product type, applications, end users and geography. By technology the market is divided into molecular and non-molecular methods. By application, the transplantation diagnostics market is divided into diagnostic and research segments. By product the transplantation diagnostics market is divided into instruments, consumables, software and services, assays and kits. By end users the transplantation market is segmented into hospital and transplant centres, Research laboratories and academic institutes. Geographical wise, the transplantation market is segmented into North America, Europe, Asia- Pacific and rest of the world.
Among the transplantation diagnostics by technology, the non-molecular method is dominating the market by occupying a largest share and the molecular method is expected to grow at a highest CAGR from 2015 to 2022. The transplantation diagnostics market by product type is segmented into three major divisions such as instruments, consumables and software & services. Among these, consumables accounts for largest share and is growing at a strong CAGR from 2015 to 2022. By applications, is segmented into two major divisions such as diagnostic and research. Among these, diagnostic accounts for largest share as well as fastest growing segment. The end-users market of transplantation diagnostics market is segmented into three major divisions, hospital & transplant centres, diagnostic laboratories and research laboratories & academic institutions. Among these, hospital and transplant centres accounts for largest share and growing at a strong CAGR.
The transplantation diagnostics market is expected to grow at a high double digit CAGR to reach $2,059.2 million by 2022. The factors driving the growth of this market are high incidence of organ and tissue transplantation procedures across the world, increasing geriatric population, coupled with an increasing population base for chronic disease, increasing healthcare awareness are likely to propel the market. In addition to this, increasing demand for early detection through non-invasive testing procedures like cell free DNA, increase in the number of deals by collaborations and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, lack of trained health care professionals, ethical issues related to transplantation, high cost and non-affordability in developed as well as in low- and middle-income countries and unfavourable reimbursement policies are hampering the growth of the market. The threats for the transplantation diagnosticsmarket include the significant gap between the number of organs donated and the number of organs required.
The transplantation diagnostics market is a highly competitive market and all the existing players in this market are involved in developing new and advanced assays to maintain their market shares. The major players in the transplantation diagnostics market include Abbott Laboratories, Inc. (U.S.), Biofortuna Ltd (U.K.), Bio-Rad Laboratories, Inc. (U.S.), CareDx, Inc. (U.S.), Illumina, Inc. (U.S.), Immucor, Inc.(U.S.), Linkage biosciences (U.S.), Qiagen N.V. (Netherlands), Roche (Switzerland), Thermo Fisher Scientific, Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
1 EXECUTIVE SUMMARY 21
2 INTRODUCTION 31
- 2.1 KEY TAKE AWAYS 31
- 2.2 REPORT DESCRIPTION 31
- 2.3 MARKETS COVERED 33
- 2.4 STAKEHOLDERS 35
- 2.5 RESEARCH METHODOLOGY 35
- 2.5.1 MARKET SIZE ESTIMATION 36
- 2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 39
- 2.5.3 SECONDARY SOURCES 40
- 2.5.4 PRIMARY SOURCES 41
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 41
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 42
- 2.5.7 ASSUMPTIONS 42
3 MARKET ANALYSIS 44
- 3.1 INTRODUCTION 44
- 3.2 MARKET SEGMENTATION 46
- 3.3 FACTORS INFLUENCING MARKET 47
- 3.3.1 DRIVERS AND OPPORTUNITIES 47
- 3.3.1.1 Increase in the rate of solid organ, tissue and stem cell transplantation 47
- 3.3.1.2 Increase in geriatric population coupled with chronic diseases 48
- 3.3.1.3 Increase in research grants and funding 49
- 3.3.1.4 Increasing demand for early detection through non-invasive testing
procedures using cell-free DNA 50
- 3.3.1.5 Growing awareness among people for organ donation and increase in
- 3.3.1 DRIVERS AND OPPORTUNITIES 47
healthcare expenditure 51
- 3.3.1.6 Technological shift from serological assays to gene-based HLA profiling 52
- 3.3.2.1 High device cost and non-affordability 52
- 3.3.2.2 Limited medical reimbursements for organ donation and transplantation procedures 53
- 3.3.2.3 Ethical issues related to transplantation 54
- 3.3.2.4 Significant gap between the number of organs donated and the number of
organs required annually is a major challenge limiting the growth of the
global transplant diagnostic market 55
- 3.4 REGULATORY AFFAIRS 56
- 3.4.1 U.S. 56
- 3.4.2 EUROPE 57
- 3.4.3 INDIA 58
- 3.4.4 CHINA 59
- 3.4.5 JAPAN 59
- 3.5 PORTERS FIVE FORCE ANALYSIS 60
- 3.5.1 THREAT OF NEW ENTRANTS 61
- 3.5.2 THREAT OF SUBSTITUTES 62
- 3.5.3 COMPETITIVE RIVALRY 63
- 3.5.4 BARGAINING POWER OF SUPPLIERS 63
- 3.5.5 BARGAINING POWER OF BUYERS 64
- 3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 65
- 3.7 RECENT AND UPCOMING PRODUCTS 67
4 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY 71
- 4.1 INTRODUCTION 71
- 4.2 MOLECULAR METHODS 74
- 4.2.1 PCR BASED MOLECULAR METHODS 78
- 4.2.1.1 SSP-PCR 82
- 4.2.1.2 SSO-PCR 84
- 4.2.1.3 Others 86
- 4.2.1.3.1 SNP-PCR 86
- 4.2.1.3.2 RFLP-PCR 87
- 4.2.2 SEQUENCING BASED MOLECULAR METHODS 89
- 4.2.2.1 NGS 92
- 4.2.2.2 SANGER SEQUENCING 95
- 4.3 NON-MOLECULAR METHODS 99
- 4.3.1 SEROLOGICAL TESTS 102
- 4.3.2 MIXED LYMPHOCYTE CULTURE ASSAY 105
- 4.3.3 FLOW CYTOMETRY 106
5 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY PRODUCT
TYPE 109
- 5.1 INTRODUCTION 109
- 5.2 INSTRUMENTS 112
- 5.3 CONSUMABLES 115
- 5.4 SOFTWARE & SERVICES 120
6 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY SCREENING
METHODS 124
- 6.1 INTRODUCTION 124
- 6.2 PRE-TRANSPLANTATION SCREENING 126
- 6.3 POST-TRANSPLANTATION SCREENING 128
7 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY APPLICATION 131
- 7.1 INTRODUCTION 131
- 7.2 DIAGNOSTIC (MEDICAL) APPLICATION 134
- 7.2.1 SOLID ORGAN TRANSPLANTATION DIAGNOSTICS 137
- 7.2.1.1 Kidney Transplantation 141
- 7.2.1.2 Heart Transplantation 143
- 7.2.1.3 Liver Transplantation 145
- 7.2.1.4 Other Transplantation 147
- 7.2.2 STEM CELL TRANSPLANTATION 150
- 7.2.3 TISSUE BASED TRANSPLANTATION 152
- 7.2.1 SOLID ORGAN TRANSPLANTATION DIAGNOSTICS 137
- 7.3 RESEARCH APPLICATIONS 154
8 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY END-USERS 157
- 8.1 INTRODUCTION 157
- 8.2 HOSPITALS AND TRANSPLANT CENTRES 159
- 8.3 DIAGNOSTIC LABORATORIES 161
- 8.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS 163
9 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY REGION 165
- 9.1 INTRODUCTION 165
- 9.2 NORTH AMERICA 167
- 9.2.1 U.S. 168
- 9.2.2 CANADA 169
- 9.3 EUROPE 182
- 9.3.1 GERMANY 183
- 9.3.2 SPAIN 183
- 9.4 ASIA-PACIFIC 196
- 9.4.1 CHINA 196
- 9.4.2 INDIA 196
- 9.4.3 AUSTRALIA 197
- 9.5 REST OF THE WORLD 210
10 COMPANY DEVELOPMENTS 223
- 10.1 INTRODUCTION 223
- 10.1.1 ACQUISTIONS & AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
AS A MAJOR GROWTH STRATEGY OF TRANSPLANTATION
DIAGNOSTICS MARKET PLAYERS 223
- 10.2 ACQUISITIONS 225
- 10.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 227
- 10.4 NEW PRODUCT LAUNCH 230
- 10.5 APPROVALS 232
- 10.6 OTHER DEVELOPMENTS 233
11 COMPANY PROFILES 235
- 11.1 ABBOTT LABORATORIES, INC. 235
- 11.1.1 OVERVIEW 235
- 11.1.2 FINANCIALS 236
- 11.1.3 PRODUCT PORTFOLIO 239
- 11.1.4 KEY DEVELOPMENTS 240
- 11.1.5 BUSINESS STRATEGY 240
- 11.1.6 SWOT ANALYSIS 241
- 11.2 BIOFORTUNA LTD 242
- 11.2.1 OVERVIEW 242
- 11.2.2 FINANCIALS 242
- 11.2.3 PRODUCT PORTFOLIO 242
- 11.2.4 KEY DEVELOPMENTS 243
- 11.2.5 BUSINESS STRATEGY 243
- 11.2.6 SWOT ANALYSIS 244
- 11.3 BIO-RAD LABORATORIES 245
- 11.3.1 OVERVIEW 245
- 11.3.2 FINANCIALS 246
- 11.3.3 PRODUCT PORTFOLIO 248
- 11.3.4 KEY DEVELOPMENTS 249
- 11.3.5 BUSINESS STRATEGY 249
- 11.3.6 SWOT ANALYSIS 250
- 11.4 CAREDX, INC. 251
- 11.4.1 OVERVIEW 251
- 11.4.2 FINANCIALS 252
- 11.4.3 PRODUCT PORTFOLIO 252
- 11.4.4 KEY DEVELOPMENTS 253
- 11.4.5 BUSINESS STRATEGY 254
- 11.4.6 SWOT ANALYSIS 255
- 11.5 ILLUMINA, INC. 256
- 11.5.1 OVERVIEW 256
- 11.5.2 FINANCIALS 257
- 11.5.3 PRODUCT PORTFOLIO 259
- 11.5.4 KEY DEVELOPMENTS 260
- 11.5.5 BUSINESS STRATEGY 261
- 11.5.6 SWOT ANALYSIS 262
- 11.6 IMMUCOR, INC. 263
- 11.6.1 OVERVIEW 263
- 11.6.2 FINANCIALS 264
- 11.6.3 PRODUCT PORTFOLIO 266
- 11.6.4 KEY DEVELOPMENTS 267
- 11.6.5 BUSINESS STRATEGY 269
- 11.6.6 SWOT ANALYSIS 270
- 11.7 LINKAGE BIOSCIENCES, INC. 271
- 11.7.1 OVERVIEW 271
- 11.7.2 FINANCIALS 271
- 11.7.3 PRODUCT PORTFOLIO 271
- 11.7.4 KEY DEVELOPMENTS 272
- 11.7.5 BUSINESS STRATEGY 273
- 11.7.6 SWOT ANALYSIS 274
- 11.8 QIAGEN N.V. 275
- 11.8.1 OVERVIEW 275
- 11.8.2 FINANCIALS 276
- 11.8.3 PRODUCT PORTFOLIO 278
- 11.8.4 KEY DEVELOPMENTS 281
- 11.8.5 BUSINESS STRATEGY 282
- 11.8.6 SWOT ANALYSIS 283
- 11.9 ROCHE HOLDINGS AG 284
- 11.9.1 OVERVIEW 284
- 11.9.2 FINANCIALS 285
- 11.9.3 PRODUCT PORTFOLIO 289
- 11.9.4 KEY DEVELOPMENTS 290
- 11.9.5 BUSINESS STRATEGY 292
- 11.9.6 SWOT ANALYSIS 293
- 11.10 THERMO FISHER SCIENTIFIC, INC. 294
- 11.10.1 OVERVIEW 294
- 11.10.2 FINANCIALS 295
- 11.10.3 PRODUCT PORTFOLIO 297
- 11.10.4 KEY DEVELOPMENTS 300
- 11.10.5 BUSINESS STRATEGY 301
- 4.2.1 PCR BASED MOLECULAR METHODS 78
Summary:
Get latest Market Research Reports on Transplantation Diagnostics. Industry analysis & Market Report on Transplantation Diagnostics is a syndicated market report, published as Transplantation Diagnostics Global Market - Forecast to 2022. It is complete Research Study and Industry Analysis of Transplantation Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
